The use of oral dosage forms is increasing are they enhance the convenience of the patients
After 72 weeks: Participants taking 5 mg of tirzepatide lost 15% of their starting body weight on average Those taking 10 mg lost an average of 19.5% Those taking the highest dose, 15 mg, lost an average of 20.9% Another phase 3 clinical trial studied the efficacy of once-daily orforglipron in people with obesity and found that it resulted in significant weight loss compared to placebo
10.1016/j.ejphar.2021.174039 14 EgeciogluE.EngelJ
Who is a Good Candidate for Peptide Therapy
GLP-1s cause your body to release more insulin, which lowers your blood sugar, and less glucagon, which raises your blood sugar
It plays a vital role in post-marketing surveillance for licensed medicines, and also accepts reports relating to unlicensed medicines, vaccines, medical devices, and e-cigarettes